Editorial: Assessing the consequences of antidepressant treatments

Editorial: Assessing the consequences of antidepressant treatments

Bibliographic Details
Main Authors:	Markus Kosel, Chong Guang Ng, Norio Yasui-Furukori
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-04-01
Series:	Frontiers in Psychiatry
Subjects:	major depressive disorder drug therapy psychedelic agents lithium menstrual bleeding citalopram
Online Access:	https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1185678/full

Similar Items

Risk-to-befit ratios of consecutive antidepressants for heavy menstrual bleeding in young women with bipolar disorder or major depressive disorder
by: Chuanjun Zhuo, et al.
Published: (2022-10-01)

Comparison of Citalopram and Metacognitive Therapy on Depression in Patients with Major Depressive Disorder
by: Gholam Reza Kheirabadi, et al.
Published: (2017-11-01)

Prevalence of Heavy Menstrual Bleeding and Its Associated Cognitive Risks and Predictive Factors in Women With Severe Mental Disorders
by: Jianmin Shan, et al.
Published: (2022-07-01)

Efficacy of empagliflozin as adjunctive therapy to citalopram in major depressive disorder: a randomized double-blind, placebo-controlled clinical trial
by: Atefeh Zandifar, et al.
Published: (2024-02-01)

From antidepressants and psychotherapy to oxytocin, vagus nerve stimulation, ketamine and psychedelics: how established and novel treatments can improve social functioning in major depression
by: Aleksandra Kupferberg, et al.
Published: (2024-10-01)

Impact of Antidepressants on Cytokine Production of Depressed Patients in Vitro
by: Alexander Munzer, et al.
Published: (2013-11-01)

Synergistic effect between citalopram and muscimol upon induction of anxiolytic- and antidepressant-like effects in male mice: An isobologram analysis
by: Elnaz Amini, et al.
Published: (2024-06-01)

Serotonin Transporter Polymorphism (5-HTTLPR) and Citalopram Effectiveness in Iranian Patients with Major Depressive Disorder
by: Shima Sahraian, et al.
Published: (2013-06-01)

Safety, tolerability, pharmacodynamic and wellbeing effects of SPL026 (dimethyltryptamine fumarate) in healthy participants: a randomized, placebo-controlled phase 1 trial
by: Ellen James, et al.
Published: (2024-01-01)

An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1)
by: Carina Joy Donegan, et al.
Published: (2023-10-01)

Natural Psychoplastogens As Antidepressant Agents
by: Jakub Benko, et al.
Published: (2020-03-01)

The Escitalopram versus Electric Current Therapy for Treating Depression Clinical Study (ELECT-TDCS): rationale and study design of a non-inferiority, triple-arm, placebo-controlled clinical trial
by: André Russowsky Brunoni, et al.

Moderators of ayahuasca’s biological antidepressant action
by: Geovan Menezes de Sousa, et al.
Published: (2022-12-01)

Cardiovascular Considerations in Antidepressant Therapy: An Evidence-Based Review
by: Habibeh Yekehtaz, et al.
Published: (2015-10-01)

Combination of Citalopram and Nortriptyline in Treatment of Moderate to Severe Major Depression: A Double-blind, Placebo- controlled Trial
by: Mohammad Reza Mohammadi, et al.
Published: (2006-04-01)

Therapeutic use of psychedelic drugs in depression disorders
by: M. Trigo
Published: (2021-04-01)

Comparison between Single-Dose and Two-Dose Psilocybin Administration in the Treatment of Major Depression: A Systematic Review and Meta-Analysis of Current Clinical Trials
by: Gianmarco Salvetti, et al.
Published: (2024-08-01)

Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trialResearch in context
by: Robin von Rotz, et al.
Published: (2023-02-01)

LSDDEP2: study protocol for a randomised, double-dummy, triple-blind, active placebo-controlled, parallel groups trial of LSD microdosing in patients with major depressive disorder
by: Dimitri Daldegan-Bueno, et al.
Published: (2024-08-01)

Effect of citalopram and sertraline on the expression of miRNA- 124, 132, and 16 and their protein targets in patients with depression
by: Mahnaz Ahmadimanesh, et al.
Published: (2023-07-01)

Changes in suicidal ideation during treatment among patients with major depressive disorder: A 6‐month naturalistic follow‐up study
by: Aoi Sato, et al.
Published: (2024-06-01)

Ketamine: A New Antidepressant?
by: Feride Karacaer
Published: (2015-03-01)

Evaluation of adolescents with heavy menstrual bleeding using the International Society of Thrombosis Haemostasis- Bleeding Assessment Tool and The Pediatric Bleeding Questionnaire scores
by: Nergiz Öner, et al.
Published: (2023-04-01)

Abnormal uterine bleeding in adolescence - three cases of heavy menstrual bleeding (HMB)
by: Dominika Zajdel, et al.
Published: (2022-12-01)

Clinical factors associated with anxiety and depression in Korean women with abnormal uterine bleeding
by: Hae Nam Lee, et al.
Published: (2021-04-01)

Clinical impact of functional CYP2C19 and CYP2D6 gene variants on treatment outcomes in patients with depression: a Danish cohort study
by: L. Thiele, et al.
Published: (2022-06-01)

Costs and Outcomes of Use of Amitriptyline, Citalopram and Fluoxetine in Major Depression: Exploratory Study
by: Ladislav Hosák, et al.
Published: (2000-01-01)

Toward therapeutic drug monitoring of citalopram in depression? Insights from a systematic review
by: Na Xu, et al.
Published: (2023-04-01)

Female sexual dysfunction and Escitalopram antidepressant
by: Ali Mahran, et al.
Published: (2022-01-01)

Impact of the antidepressant citalopram on the behaviour of two different life stages of brown trout
by: Michael Ziegler, et al.
Published: (2020-03-01)

Clinical perspectives on the influence of drug formulation on patient tolerability and use of commonly prescribed antidepressants in major depressive disorder
by: Matthew A Fuller, et al.
Published: (2013-01-01)

Effects of psychedelics on neurogenesis and broader neuroplasticity: a systematic review
by: Rafael V. Lima da Cruz, et al.
Published: (2024-12-01)

The Duration of Menstrual Blood Loss: Historical to Current Understanding
by: Marwan Habiba, et al.
Published: (2023-07-01)

Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, placebo-controlled and delayed-start, neuroimaging trial in depression
by: Joshua M. Poulin, et al.
Published: (2024-07-01)

Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial
by: Muhammad Ishrat Husain, et al.
Published: (2023-07-01)

Ketamine-assisted psychotherapy in adolescents with multiple psychiatric diagnoses
by: Philip E. Wolfson, et al.
Published: (2023-03-01)

PSYCHEDELICS: CLINICAL EVIDENCE AND THERAPEUTIC MECHANISMS IN PSYCHIATRY
by: JANI KAJANOJA, OSKARI KANTONEN, JUUSO KÄHÖNEN
Published: (2024-11-01)

Efficacy of Citalopram in Improving Depression and Quality of Life in Acute Coronary Syndrome
by: Farzane Robatjazi, et al.
Published: (2018-03-01)

Depression, Anxiety, and Quality of Life in Breast Cancer Patients with Depression Receiving Citalopram and Supportive Group Psychotherapy: A Six-month Longitudinal Study
by: Novin Nikbakhsh, et al.
Published: (2019-06-01)

Simulated synapse loss induces depression-like behaviors in deep reinforcement learning
by: Eric Chalmers, et al.
Published: (2024-11-01)